Invectys Sa

Calculating rank

USPTO Granted Patents = 7

Forward Citations = 13

Loading Chart...

6 inventors (with patents filed for the assignee):

Pierre Langlade Demoyen (7 out of 17 patents)

Maria Loustau (7 out of 7 patents)

Julien Caumartin (7 out of 8 patents)

4. François Anna (4 out of 4 patents)

5. Thierry Huet (3 out of 6 patents)

6. Maria Wehbe (3 out of 3 patents)

7 patents: Sort by Forward Citations

1. 12297275 - Chimeric antigen receptors against multiple HLA-G isoforms (2025-05-13),

2. 11634494 - Anti HLA-G specific antibodies (2023-04-25),

3. 11505608 - Chimeric antigen receptors against multiple HLA-G isoforms (2022-11-22),

4. 11325977 - Chimeric antigen receptors against multiple HLA-G isoforms (2022-05-10),

5. 11312774 - Anti HLA-G specific antibodies (2022-04-26),

6. 11117971 - Chimeric antigen receptors against multiple HLA-G isoforms (2021-09-14),

7. 11111302 - Anti HLA-G specific antibodies (2021-09-07),

Company Overview

Invectys Sa is a biotechnology company specialized in developing innovative cancer immunotherapies. Their proprietary technology targets tumor cells and stimulates the immune system to fight against cancer. With a focus on precision medicine, Invectys Sa aims to provide personalized treatment options for patients with various types of cancer.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#451 in Paris

#2,222 in France

Paris, France

Invectys Sa

Forward Citations = 13

6 inventors:

Pierre Langlade Demoyen (7 out of 17 patents)

Maria Loustau (7 out of 7 patents)

Julien Caumartin (7 out of 8 patents)

4. François Anna (4 out of 4 patents)

5. Thierry Huet (3 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Invectys Sa. Retrieved from https://idiyas.com/company/invectys-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]